Sept 29 (Reuters) - Genmab A/S ( GMAB ):
* GENMAB TO ACQUIRE MERUS, EXPANDING LATE-STAGE PIPELINE AND
ACCELERATING INTO A WHOLLY OWNED MODEL
* GENMAB A/S ( GMAB ) - TO BUY MERUS FOR USD 8.0 BILLION
* GENMAB A/S ( GMAB ) - DEAL EXPECTED TO BE ACCRETIVE TO EBITDA BY
2029
* GENMAB A/S ( GMAB ) - USD 97.00 PER SHARE REPRESENTS 41% PREMIUM
OVER
CLOSING PRICE
Source text:
Further company coverage: